HOME >> BIOLOGY >> NEWS
Jefferson scientists find blood vessel-building protein halts blood vessels from forming in cancer

(PHILADELPHIA) A piece of the protein cellular scaffolding involved in building blood vessels during development might have the opposite effect in tumors.

Cell biologists at Jefferson Medical College and the Kimmel Cancer Center of Thomas Jefferson University in Philadelphia have found that the protein fragment endorepellin blocks both skin and lung cancer tumors from progressing in animal models by preventing their ability to recruit new blood vessels, a process called angiogenesis. They showed that endorepellin has surprisingly powerful effects on halting a cancer tumor's ability to move about and spread.

The researchers believe that these latest findings, appearing November 15, 2006 in the Journal of the National Cancer Institute, could lead to a new type of tumor inhibitor that might be used to prevent cancer from spreading to other areas in the body.

The researchers, led by Renato Iozzo, M.D., professor of pathology, anatomy and cell biology at Jefferson Medical College of Thomas Jefferson University, used two animal models of cancer to study squamous cell carcinoma and lung carcinoma. When they injected animals with artificially created "recombinant" endorepellin, they discovered that it blocked tumor growth, metabolism and angiogenesis. They also found for the first time that endorepellin targets the tumor endothelial cells, blocking the creation of new blood vessels.

"These findings have major implications for cancer treatments for a range of solid tumors such as lung, prostate and breast," Dr. Iozzo says. "All of these tumors depend on angiogenesis, so we think this could be an effective adjuvant therapy for cancer."

Endorepellin is part of the protein perlecan, which plays fundamental roles in vascular biology as scaffolding for blood vessel formation in development. In cancer, perlecan not only regulates growth factor activity, but also is a barrier to invading cancer cells.


'"/>

Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University
14-Nov-2006


Page: 1 2

Related biology news :

1. Jefferson scientists patent dramatically improves
2. Marker predicts pancreatic cancer outcome after surgery, Jefferson surgeon finds
3. Tiny genes may increase cancer susceptibility, Jefferson scientists find
4. Jefferson scientists use gene therapy to reverse heart failure in animals
5. Jefferson researchers discovery may change thinking on how viruses invade the brain
6. Jefferson scientists identify protein key to breast cancer spread, potential new drug target
7. Jefferson scientists find rabies-based vaccine could be effective against HIV
8. Jefferson scientists uncover gene mutation that cuts colon polyps, may suppress cancer
9. Targeting the adrenal gland could be key strategy against heart failure, Jefferson scientists show
10. Jefferson scientists find guardian genes choices crucial to stopping cancer process
11. Jefferson researchers uncover new way nature turns genes on and off

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/1/2019)... ... ... Stay on top of current hot topics through free webinars presented by leading experts ... so be sure to register today to save your place! Participate in the discussion ... upcoming webinars: , CLINICAL TRIALS , April 2 – They’re Talking. Are You Listening? ...
(Date:3/29/2019)... ... March 28, 2019 , ... In the wake of the ... dedicated to Chinese biobanks was launched in July 2018, in an agreement between ... Branch, China Medicinal Biotech Association (BBCMBA). The one-year pilot programme offered two testing ...
(Date:3/29/2019)... Md. (PRWEB) , ... March 29, 2019 , ... ... Stem/Stromal Cell (hMSC) biomanufacturing systems, will attend the Society for Biomaterials Annual Meeting ... gives us the opportunity to connect with academic, healthcare, governmental and business professionals ...
Breaking Biology News(10 mins):
(Date:4/8/2019)... ... April 09, 2019 , ... To support ... center Chan Zuckerberg Biohub (CZ Biohub) has chosen Geneious Biologics to help them ... of CZ Biohub’s efforts to establish new approaches to inform the discovery of ...
(Date:3/27/2019)... ... March 26, 2019 , ... A leader in the field of Regenerative ... across the United States and Canada since 2004. The primary indications for VetStem ... in the dog, cat, and horse. Recently, VetStem teamed up with the ...
(Date:3/23/2019)... KING OF PRUSSIA, Pa. (PRWEB) , ... March ... ... announce the introduction of its LenS3 Multi-Angle Light Scattering (MALS) detector , ... of gyration (Rg) of synthetic polymers, polysaccharides, proteins, and biopolymers. A novel optical ...
(Date:3/19/2019)... ALISO VIEJO, Calif. (PRWEB) , ... March 19, ... ... subsidiary of Konica Minolta, Inc. (Konica Minolta) today announced the formation of their ... dedicated to the advancement of precision medicine that takes into account individual variability ...
Breaking Biology Technology:
Cached News: